Coverage

Experts say any short-term financial benefit will be outweighed by long-term health costs related to obesityFaced with high demand for GLP-1 drugs, some American cities and states that previously covered the cost of the weight-loss medication for low-income residents and public employees have now started to restrict or eliminate coverage.The pullback stems from the dramatic increase in public spending on drugs such as Ozempic and Wegovy in recent years. Continue reading...

• HHS issued a final rule on April 7, 2026, permanently extending Medicare telehealth flexibilities introduced during COVID-19, covering 85 million Medicaid enrollees. • Audio-only visits now reimbursable at $18-$40 per session, with $37 billion allocated through 2030 to rural providers. • Addresses access gaps in 20% of US counties lacking specialists; 'This bridges urban-rural divides,' said HHS Secretary.

• Major U.S. health insurers are limiting coverage of GLP-1 drugs like Ozempic and Wegovy to their original FDA-approved use for diabetes management, excluding weight loss treatments. • According to industry analyst Andy, this shift reverses prior expansions amid rising costs and supply shortages, affecting millions of patients seeking obesity care. • The policy change aims to control spending on these high-demand medications, which have seen off-label use surge, potentially pushing patients toward alternatives or out-of-pocket payments.

• Patients and providers in Colorado reported rising health care costs due to Trump administration policies including H.R.1 Medicaid requirements and ended ACA tax credits, discussed at a March 25 virtual roundtable with Sen. John Hickenlooper. • Nearly 250,000 Coloradans risk losing Medicaid coverage, exacerbating rural health care deserts where 82% of hospitals operate on unsustainable margins, per Craig Memorial Regional Health CEO Jennifer Riley. • Uninsured patients will seek emergency care at the highest cost level, straining providers and worsening access, especially for women's health services.

• The Centers for Medicare & Medicaid Services announced expanded coverage for advanced lipid panels and inflammatory biomarker testing starting April 1, 2026, for beneficiaries age 50 and older. • The expansion removes prior authorization requirements for up to two tests annually, reflecting new evidence that early cardiovascular risk detection improves outcomes and reduces emergency hospitalizations by 18%. • CMS estimates the policy will affect approximately 28 million Medicare beneficiaries and cost $120 million annually while potentially preventing 8,000 heart attacks and strokes per year.

• The Trump administration launched investigations on March 19, 2026, into 13 states requiring health insurance to cover abortion, citing violations of the Weldon Amendment. • Targeted states include California, Colorado, Delaware, Illinois, Maine, Maryland, Massachusetts, Minnesota, New Jersey, New York, Oregon, Vermont, and Washington, most with Democratic governors. • HHS Civil Rights Director Paula M. Stannard stated the probes address states' disregard for protections allowing health entities to opt out of abortion coverage on conscience grounds.

US president on social media said he was ‘thrilled’ that Brendan Carr was looking into broadcasters’ licenses Sign up for the Breaking News US email to get newsletter alerts in your inbox Donald Trump reinforced comments made by Brendan Carr, the chair of the Federal Communications Commission (FCC), threatening the broadcast licenses of news organizations that report unfavorably on the war in Iran.In a Truth Social post Sunday night, Trump said he was “thrilled” that Carr was “looking at the licenses of some of these Corrupt and Highly Unpatriotic ‘News’ Organizations. They get Billions of Dollars of FREE American Airwaves, and use it to perpetuate LIES …”. Continue reading...